GMED Stock Chart & Stats
$1390.45
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$950.00 - $1,916.40
Previous CloseN/A
VolumeN/A
Average Volume (3M)67.00
Market Cap
$181.44B
Enterprise Value$11.39K
Total Cash (Recent Filing)$629.85M
Total Debt (Recent Filing)$115.22M
Price to Earnings (P/E)17.6
Beta0.22
Next Earnings
Aug 06, 2026EPS Estimate
19.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.35
Shares Outstanding113,236,100
10 Day Avg. Volume200
30 Day Avg. Volume67
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)2.58
Price to Sales (P/S)4.02
P/FCF Ratio20.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,859.44Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GMED FAQ
What was Globus Medical’s price range in the past 12 months?
Globus Medical lowest stock price was $950.00 and its highest was $1916.40 in the past 12 months.
What is Globus Medical’s market cap?
Globus Medical’s market cap is $181.44B.
When is Globus Medical’s upcoming earnings report date?
Globus Medical’s upcoming earnings report date is Aug 06, 2026 which is in 11 days.
How were Globus Medical’s earnings last quarter?
Globus Medical released its earnings results on May 07, 2026. The company reported $19.61 earnings per share for the quarter, beating the consensus estimate of $16.108 by $3.502.
Is Globus Medical overvalued?
According to Wall Street analysts Globus Medical’s price is currently Undervalued.
Does Globus Medical pay dividends?
Globus Medical does not currently pay dividends.
What is Globus Medical’s EPS estimate?
Globus Medical’s EPS estimate is 19.22.
How many shares outstanding does Globus Medical have?
Globus Medical has 113,236,100 shares outstanding.
What happened to Globus Medical’s price movement after its last earnings report?
Globus Medical reported an EPS of $19.61 in its last earnings report, beating expectations of $16.108. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Globus Medical?
Currently, no hedge funds are holding shares in MX:GMED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Globus Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$1,859.44 (― Downside)
$1,859.44 (― Downside)
Blogger Sentiment
Bullish
MX:GMED Sentiment 70%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
39.56%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
15.46%
Trailing 12-Months
Company Description
Globus Medical
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
GMED Stock 12 Month Forecast
Average Price Target
$1,859.44